Date Filed | Type | Description |
01/20/2023 |
4
| Deignan Charles A. (CFO) has filed a Form 4 on Clearside Biomedical, Inc.
Txns:
| Sold 14,030 shares
@ $1.5, valued at
$21k
|
|
01/06/2023 |
4
| Deignan Charles A. (CFO) has filed a Form 4 on Clearside Biomedical, Inc.
Txns:
| Granted 187,500 options to buy
@ $1.48, valued at
$277.5k
|
|
12/20/2022 |
4
| Deignan Charles A. (CFO) has filed a Form 4 on Clearside Biomedical, Inc.
Txns:
| Exercised 23,636 options to buy
@ $0.4, valued at
$9.5k
|
|
01/28/2022 |
4/A
| Deignan Charles A. (CFO) has filed a Form 4 on Clearside Biomedical, Inc.
Txns:
| Granted 46,250 shares
@ $0 Granted 138,750 options to buy
@ $2.19, valued at
$303.9k
|
|
01/20/2022 |
4
| Deignan Charles A. (CFO) has filed a Form 4 on Clearside Biomedical, Inc.
Txns:
| Granted 43,750 shares
@ $0 Sold 8,833 shares
@ $2.09, valued at
$18.5k
Granted 131,250 options to buy
@ $2.19, valued at
$287.4k
|
|
09/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/03/2020 |
4
| Deignan Charles A. (CFO) has filed a Form 4 on Clearside Biomedical, Inc.
Txns:
| Sold 14,992 shares
@ $1.88, valued at
$28.2k
|
|
01/10/2020 |
4
| Deignan Charles A. (CFO) has filed a Form 4 on Clearside Biomedical, Inc.
Txns:
| Granted 25,000 shares
@ $0 Granted 75,000 options to buy
@ $2.37, valued at
$177.8k
|
|
11/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/20/2019 |
4
| Deignan Charles A. (CFO) has filed a Form 4 on Clearside Biomedical, Inc.
Txns:
| Granted 70,000 shares
@ $0 |
|
06/04/2019 |
4
| Deignan Charles A. (CFO) has filed a Form 4 on Clearside Biomedical, Inc.
Txns:
| Granted 50,000 shares
@ $0 |
|
03/18/2019 |
4
| Deignan Charles A. (CFO) has filed a Form 4 on Clearside Biomedical, Inc.
Txns:
| Bought 10,000 shares
@ $1.36, valued at
$13.6k
|
|
02/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/26/2018 |
4
| Deignan Charles A. (CFO) has filed a Form 4 on Clearside Biomedical, Inc.
Txns:
| Bought 500 shares
@ $11.79, valued at
$5.9k
|
|
12/12/2017 |
4
| Deignan Charles A. (CFO) has filed a Form 4 on Clearside Biomedical, Inc.
Txns:
| Granted 96,000 options to buy
@ $5.89, valued at
$565.4k
|
|
08/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/19/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/25/2016 |
4
| Deignan Charles A. (CFO) has filed a Form 4 on Clearside Biomedical, Inc.
Txns:
| Granted 30,000 options to buy
@ $6.49, valued at
$194.7k
|
|
06/01/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |